Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of canagliflozin in children and adolescents (aged 10 to <18) with type 2 diabetes has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2025-03-12